Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127585451 | 12758545 | 1 | I | 20160905 | 20160919 | 20160919 | EXP | BR-PFIZER INC-2016420072 | PFIZER | 62.00 | YR | F | Y | 90.00000 | KG | 20160919 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127585451 | 12758545 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP (1,5 MCG OF LATANOPROST) EACH EYE | U | L31214 | 20597 | 2 | GTT | EYE DROPS, SOLUTION | |||||
| 127585451 | 12758545 | 2 | SS | XALATAN | LATANOPROST | 1 | UNK | U | L23965 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 127585451 | 12758545 | 3 | C | PREDCORT | 2 | Ophthalmic | 4 IN 4 HOURS 1 DROP | 0 | 1 | GTT |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127585451 | 12758545 | 1 | Glaucoma |
| 127585451 | 12758545 | 3 | Cataract operation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127585451 | 12758545 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127585451 | 12758545 | Cataract | |
| 127585451 | 12758545 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127585451 | 12758545 | 3 | 20160824 | 0 |